Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3254.85
(1.04%)
INR 3254.85
(1.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 40.22 Billion INR | -25.08% |
| 2022 | 53.68 Billion INR | 31.92% |
| 2021 | 40.69 Billion INR | -16.51% |
| 2020 | 48.74 Billion INR | -16.54% |
| 2019 | 58.4 Billion INR | -3.28% |
| 2018 | 60.38 Billion INR | -6.56% |
| 2017 | 64.62 Billion INR | 157.45% |
| 2016 | 25.1 Billion INR | 6.74% |
| 2015 | 23.51 Billion INR | -13.79% |
| 2014 | 27.28 Billion INR | 141.04% |
| 2013 | 11.31 Billion INR | 63.32% |
| 2012 | 6.92 Billion INR | 19.74% |
| 2011 | 5.78 Billion INR | 47.41% |
| 2010 | 3.92 Billion INR | -24.84% |
| 2009 | 5.22 Billion INR | 8.25% |
| 2008 | 4.82 Billion INR | 34.14% |
| 2007 | 3.59 Billion INR | 20.36% |
| 2006 | 2.98 Billion INR | 12.62% |
| 2005 | 2.65 Billion INR | 24.98% |
| 2004 | 2.12 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 30.48 Billion INR | 0.0% |
| 2023 FY | 40.22 Billion INR | -25.08% |
| 2023 Q2 | 44.89 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 40.22 Billion INR | 0.0% |
| 2022 Q2 | 40.83 Billion INR | 0.0% |
| 2022 FY | 53.68 Billion INR | 31.92% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 53.68 Billion INR | 0.0% |
| 2021 FY | 40.69 Billion INR | -16.51% |
| 2021 Q2 | 43.87 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 40.69 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 39.52 Billion INR | 0.0% |
| 2020 FY | 48.74 Billion INR | -16.54% |
| 2020 Q4 | 48.74 Billion INR | 0.0% |
| 2019 Q4 | 58.4 Billion INR | 0.0% |
| 2019 FY | 58.4 Billion INR | -3.28% |
| 2019 Q2 | 43.09 Billion INR | 0.0% |
| 2018 Q4 | 60.38 Billion INR | 0.0% |
| 2018 Q2 | 56.96 Billion INR | 0.0% |
| 2018 FY | 60.38 Billion INR | -6.56% |
| 2017 FY | 64.62 Billion INR | 157.45% |
| 2017 Q4 | 64.62 Billion INR | 0.0% |
| 2017 Q2 | 23.49 Billion INR | 0.0% |
| 2016 Q4 | 25.1 Billion INR | 0.0% |
| 2016 FY | 25.1 Billion INR | 6.74% |
| 2016 Q2 | 20.67 Billion INR | 0.0% |
| 2015 Q4 | 23.51 Billion INR | 0.0% |
| 2015 Q2 | 22.74 Billion INR | 0.0% |
| 2015 FY | 23.51 Billion INR | -13.79% |
| 2014 Q2 | 22.41 Billion INR | 0.0% |
| 2014 Q4 | 27.28 Billion INR | 0.0% |
| 2014 FY | 27.28 Billion INR | 141.04% |
| 2013 Q2 | 9.13 Billion INR | 0.0% |
| 2013 Q4 | 11.31 Billion INR | 0.0% |
| 2013 FY | 11.31 Billion INR | 63.32% |
| 2012 Q4 | 6.92 Billion INR | 0.0% |
| 2012 FY | 6.92 Billion INR | 19.74% |
| 2011 Q4 | 5.78 Billion INR | 0.0% |
| 2011 FY | 5.78 Billion INR | 47.41% |
| 2010 FY | 3.92 Billion INR | -24.84% |
| 2009 FY | 5.22 Billion INR | 8.25% |
| 2008 FY | 4.82 Billion INR | 34.14% |
| 2007 FY | 3.59 Billion INR | 20.36% |
| 2006 FY | 2.98 Billion INR | 12.62% |
| 2005 FY | 2.65 Billion INR | 24.98% |
| 2004 FY | 2.12 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bajaj HealthCare Limited | 3.32 Billion INR | -1108.445% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 352.8 Million INR | -11300.227% |
| Alpa Laboratories Limited | 52.46 Million INR | -76560.631% |
| Alkem Laboratories Limited | 14.18 Billion INR | -183.557% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -683.771% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -87369.01% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 39.497% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -3928.441% |
| Brooks Laboratories Limited | 56.41 Million INR | -71188.041% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -226.745% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -23354.63% |
| Divi's Laboratories Limited | 30 Million INR | -133966.667% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -100.899% |
| Hester Biosciences Limited | 2.44 Billion INR | -1545.811% |
| Eris Lifesciences Limited | 27.81 Billion INR | -44.61% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -24097.43% |
| FDC Limited | 205.18 Million INR | -19501.823% |
| Granules India Limited | 13.15 Billion INR | -205.841% |
| Gufic Biosciences Limited | 3.32 Billion INR | -1108.114% |
| Indoco Remedies Limited | 6.71 Billion INR | -498.548% |
| Ipca Laboratories Limited | 14.38 Billion INR | -179.624% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -44883.783% |
| Megasoft Limited | 1.47 Billion INR | -2635.18% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1979.311% |
| Lasa Supergenerics Limited | 220.76 Million INR | -18118.715% |
| Laurus Labs Limited | 25.77 Billion INR | -56.049% |
| Lupin Limited | 29.21 Billion INR | -37.656% |
| Mankind Pharma Limited | 2.07 Billion INR | -1841.378% |
| Medicamen Biotech Limited | 308.17 Million INR | -12951.153% |
| Medico Remedies Limited | 80.5 Million INR | -49860.25% |
| NATCO Pharma Limited | 3.71 Billion INR | -983.513% |
| Procter & Gamble Health Limited | 95.6 Million INR | -41971.13% |
| Piramal Pharma Limited | 47.1 Billion INR | 14.61% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -6477.269% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | -22.859% |
| Windlas Biotech Limited | 36.41 Million INR | -110364.158% |
| Sigachi Industries Limited | 1.43 Billion INR | -2711.571% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -6088.035% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -5448.612% |
| Unichem Laboratories Limited | 2.47 Billion INR | -1524.957% |
| ZIM Laboratories Limited | 1.08 Billion INR | -3595.862% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -400.124% |
| Wanbury Limited | 1.16 Billion INR | -3352.817% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -232614.228% |
| Bal Pharma Limited | 1.39 Billion INR | -2780.09% |
| Strides Pharma Science Limited | 25.16 Billion INR | -59.802% |
| Venus Remedies Limited | 413.3 Million INR | -9631.43% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -1309.991% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -532.851% |
| Shilpa Medicare Limited | 9.37 Billion INR | -329.064% |
| Aarti Drugs Limited | 5.64 Billion INR | -612.779% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -12177.167% |
| Suven Life Sciences Limited | 7.09 Million INR | -566618.332% |
| Ind-Swift Limited | 10.13 Billion INR | -296.649% |
| Valiant Laboratories Limited | 767.08 Million INR | -5143.233% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -964.979% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -297.627% |
| Themis Medicare Limited | 957.92 Million INR | -4098.672% |
| Hikal Limited | 8.17 Billion INR | -391.94% |
| Sequent Scientific Limited | 4.87 Billion INR | -724.699% |
| Novartis India Limited | 69.7 Million INR | -57604.448% |
| Wockhardt Limited | 23.56 Billion INR | -70.713% |
| Jubilant Pharmova Limited | 36.64 Billion INR | -9.771% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -916281.864% |
| Neuland Laboratories Limited | 953.89 Million INR | -4116.393% |
| Morepen Laboratories Limited | 289.99 Million INR | -13769.348% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -12609.146% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -3983.56% |